INS and pancreatic insulinoma: Specifically, the perfect model for INS would include typical insulinoma-associated mutations (e.g. YY1), exclude PNET mutations not associated with INS (e.g. DAXX/ATRX), retain insulin secretion and have a slow growth rate [8], [9], [10].